Heng Cao

No. 79 Qingchun Road
Hangzhou, 310003, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Ivarmacitinib in patients with active ankylosing spondylitis: subgroup analysis based on key baseline features from a phase II/III trial.

Ivarmacitinib in patients with active ankylosing spondylitis: subgroup analysis based on key baseline features from a phase II/III trial.

Journal: Clinical rheumatology

Published: April 27, 2026

Targeting RIPK1 is a promising therapeutic avenue for systemic lupus erythematosus.

Targeting RIPK1 is a promising therapeutic avenue for systemic lupus erythematosus.

Journal: Clinical rheumatology

Published: July 11, 2025

Inhibition of DJ-1 protects from lupus onset and severity.

Inhibition of DJ-1 protects from lupus onset and severity.

Journal: Scientific reports

Published: May 26, 2025

Co-infusion of CD19-targeting and BCMA-targeting CAR-T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial.

Co-infusion of CD19-targeting and BCMA-targeting CAR-T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial.

Journal: Nature medicine

Published: April 18, 2025

Association of NXP2 autoantibodies with a more severe clinical phenotype of juvenile dermatomyositis.

Association of NXP2 autoantibodies with a more severe clinical phenotype of juvenile dermatomyositis.

Journal: Clinical and experimental rheumatology

Published: April 09, 2025

Inhibition of ACSL4 Attenuates Behavioral Deficits by Regulating Ferroptosis in a Murine Model of Systemic Lupus Erythematosus.

Inhibition of ACSL4 Attenuates Behavioral Deficits by Regulating Ferroptosis in a Murine Model of Systemic Lupus Erythematosus.

Journal: International journal of molecular sciences

Published: March 03, 2025

Prevalence of and risk factors for important comorbidities of systemic lupus erythematosus using data from a multicenter Chinese cohort registry: A cross-sectional study.

Prevalence of and risk factors for important comorbidities of systemic lupus erythematosus using data from a multicenter Chinese cohort registry: A cross-sectional study.

Journal: Clinical rheumatology

Published: May 29, 2024

The causal relationship between obstructive sleep apnea and rheumatic disease: A bidirectional Mendelian randomization study.

The causal relationship between obstructive sleep apnea and rheumatic disease: A bidirectional Mendelian randomization study.

Journal: Rheumatology and immunology research

Published: May 02, 2024

Early identification of macrophage activation syndrome secondary to systemic lupus erythematosus with machine learning.

Early identification of macrophage activation syndrome secondary to systemic lupus erythematosus with machine learning.

Journal: Arthritis research & therapy

Published: February 02, 2024

Predictors of progression in idiopathic inflammatory myopathies with interstitial lung disease.

Predictors of progression in idiopathic inflammatory myopathies with interstitial lung disease.

Journal: Journal of translational internal medicine

Published: August 03, 2023

An externally validated clinical-laboratory nomogram for myocardial involvement in adult idiopathic-inflammatory-myopathy patients.

An externally validated clinical-laboratory nomogram for myocardial involvement in adult idiopathic-inflammatory-myopathy patients.

Journal: Clinical rheumatology

Published: May 12, 2023

The potential role of 18 F-FDG PET/CT in dermatomyositis with cardiac involvement: A case report.

The potential role of 18 F-FDG PET/CT in dermatomyositis with cardiac involvement: A case report.

Journal: International journal of rheumatic diseases

Published: August 18, 2022

Showing 1-12 of 32

Last Updated: 09/26/2026